Determinant | Test Uptake % (No.) | Not Tested % (No.) | OR (95% CI)a |
---|---|---|---|
Higher prevalence area | |||
Hotspot A (n=2,891) | 50.2 (1,450) | 49.8 (1,441) | 1.05 (0.95–1.16) |
Hotspot B (n=3,949) | 50.2 (1,984) | 49.8 (1,965) | 1 [Reference] |
Sex | |||
Male (n=3,417) | 46.0 (1,571) | 54.0 (1,846) | 1 [Reference]b |
Female (n=3,423) | 54.4 (1,863) | 45.6 (1,560) | 1.41 (1.28–1.55) |
Age, y | |||
40–49c (n=1,891) | 35.0 (662) | 65.0 (1,229) | 1 [Reference]b |
50–59 (n=2,531) | 51.0 (1,292) | 49.0 (1,239) | 1.93 (1.71–2.18) |
60–70d (n=2,418) | 61.2 (1,480) | 38.8 (938) | 2.95 (2.60–3.34) |